ABCA1-Reducing Agents for Extracellular Vesicle Secretion

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The mechanism of extracellular vesicle secretion from cells is not well understood, making efficient production of these vesicles for therapeutic or carrier applications difficult.

Innovation Solution

A secretion booster containing an ABCA1 reducing agent, such as miR-3202 or an antibody against ABCA1 protein, is used to enhance extracellular vesicle secretion by reducing ABCA1 expression or function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods are used for extracellular vesicle production, then the production process is simple, but the secretion efficiency is low

Engineering Contradiction:

Improveextracellular vesicle secretion efficiencyVSAvoidproduction process complexity

Core Design Contradiction:

ProductivityVSDevice complexity

Solution Approach 1:

The invention changes the biochemical parameter ABCA1 expression level to control EV secretion efficiency. By reducing ABCA1 expression through reducing agents, the secretion efficiency is significantly improved without requiring complex production systems

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The invention introduces an intermediary substance (ABCA1 reducing agent) that mediates between the cell and the EV secretion process. This intermediary enables efficient EV production by modulating the ABCA1 pathway

Inventive Principle:

Principle #24Intermediary (Mediator)

2Productivity

If the secretion mechanism is not clarified, then the approach is straightforward, but the production efficiency cannot be improved

Engineering Contradiction:

Improveextracellular vesicle production efficiencyVSAvoidsecretion mechanism understanding

Core Design Contradiction:

ProductivityVSDifficulty of detecting and measuring

Solution Approach 1:

The invention establishes a feedback mechanism by identifying ABCA1 as a key regulatory point in EV secretion. By monitoring and controlling ABCA1 levels, the secretion process can be optimized and scaled up efficiently

Inventive Principle:

Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Boosts extracellular vesicle secretion from cells, enabling efficient production of extracellular vesicles for therapeutic and carrier applications, particularly in drug delivery systems.

Implementation Method 1

containing an ABCA1 reducing agent

Methodology Applied

Scientific EffectGene silencing:

Implementation Method 2

such as miR-3202

Methodology Applied

Scientific EffectRNA interference:

Data Source

PatentUS20250270564A1Extracellular vesicle secretion booster for boosting extracellular vesicle secretion, and use thereof

Publication Date: 2025.08.28 THEORIA SCI

AI summary

Provided are a novel secretion booster and secretion boosting method with respect to extracellular vesicle secretion from cells. The extracellular vesicle secretion booster of the present invention contains an ABCA1 reducing agent. The extracellular vesicle secretion boosting method of the present invention includes boosting extracellular vesicle secretion by causing a target having a cell to coexist with the extracellular vesicle secretion booster of the present invention.